Business Wire

Legend Biotech Announces Submission of New Drug Application to Japanese Regulatory Authority for BCMA CAR-T Therapy Cilta-cel for the Treatment of Relapsed or Refractory ...

SOMERSET, N.J.--(BUSINESS WIRE)--Legend Biotech Corporation (NASDAQ: LEGN), a global, clinical-stage biotechnology company developing and manufacturing novel therapies, announced today the submission ...
Nasdaq

Krystal Biotech Announces EMA Validation of Marketing Authorization Application for VYJUVEK for the Treatment of Dystrophic Epidermolysis Bullosa

PITTSBURGH, Nov. 27, 2023 (GLOBE NEWSWIRE) -- Krystal Biotech, Inc. (the “Company”) (NASDAQ: KRYS), a commercial-stage biotechnology company focused on the discovery, development and commercialization ...

YD Bio Limited Announces Strategic Partnership with YC Biotech Co., Ltd. to Establish a Taiwan-U.S. Dual-Core Regulatory Platform

YD Bio Limited (“YD Bio Ltd” or the “Company”) (Nasdaq: YDES), a biotechnology company advancing DNA methylation-based cancer detection technology and ophthalmologic innovations, today announced that ...

Andrew Hillman Launches National Grant Program to Advance Innovation and Leadership in Biotechnology Education

Dallas Entrepreneur Launches $1,000 Andrew Hillman Biotech Grant for Undergraduates DALLAS, TX, UNITED STATES, February ...
Pharmabiz

YD Bio partners with YC Biotech to establish Taiwan-US dual-core regulatory platform

YD Bio partners with YC Biotech to establish Taiwan-US dual-core regulatory platform: Taipei, Taiwan Saturday, February 28, 2026, 15:00 Hrs [IST] YD Bio Limited, a biotechnology c ...
Seeking Alpha

Purple Biotech and Mor Research Applications Announce Research Collaboration to Identify Promising Investigational Oncology Treatments

REHOVOT, Israel, Jan. 03, 2023 (GLOBE NEWSWIRE) -- Purple Biotech Ltd. ("Purple Biotech", or the "Company") (NASDAQ/TASE: PPBT), a clinical-stage company developing first-in-class, effective and ...
WHNT

Krystal Biotech Announces Clinical Data on Topical Application of B-VEC to the Eye to Treat Ocular Complications in a Patient with Dystrophic Epidermolysis Bullosa Under a ...

Topical application of B-VEC to the eye was well tolerated and patient showed significant improvement of visual acuity and complete corneal re-epithelization PITTSBURGH, April 24, 2023 (GLOBE NEWSWIRE ...
Nature

Chitinases And Their Applications In Biotechnology

Chitinases are specialised enzymes that catalyse the degradation of chitin, one of the most abundant natural polysaccharides. Found across diverse biological domains, these enzymes play crucial roles ...
Business Insider

EQS-Adhoc: BRAIN Biotech AG: prioritizing development of therapeutic applications of the Akribion Genomics technology platform (genome-editing)

EQS-Ad-hoc: BRAIN Biotech AG / Key word(s): Strategic Company Decision BRAIN Biotech AG: prioritizing development of therapeutic applications of the Akribion Genomics technology platform ...

E-Biotech® Launches Patent-Pending AI Regulatory Intelligence Infrastructure for Pharmaceutical and GMP Compliance

E-Biotech® today formally announced the launch of its patent-pending artificial intelligence infrastructure platform for pharmaceutical and GMP compliance, following its public unveiling during a live ...
NJBIZ

Leaders discuss future of biotech at Princeton roundtable

NJBIZ was on the scene as a group of key leaders and stakeholders gathered Friday for a timely discussion about the biotechnology sector. It brought together a slew of commissioners, lawmakers, ...